In patients with hip pain refractory to conventional pain control measures, CT-guided obturator nerve block can provide relief from pain in the short to medium term. The posterior approach offers safe, reliable and effective access to the nerve, in a procedure which is well-tolerated by the patient.

Airtraq® can be used for elective intubation in patients with restricted neck movements.

Airtraq® can be used for elective intubation in patients with restricted neck movements.

Background: Fluid replacement is one of the important issues in the management of burn cases. Objective: To compare the outcome between Ringer lactate and Hydroxyethyl starches (HESs) in cases with burn injuries. Methodology: Study design: Randomized controlled trial. Place and duration of study: Department of Plastic Surgery, Sheikh Zayed Hospital, Rahim Yar Khan, from June to December 2018. Study subjects selected were those who had a burn of any type (thermal, chemical, electric) and at least more than 10% of the surface area of the body. The cases were then divided into two equal groups. The fluid requirement was calculated according to the Parkland formula. After this, the cases in group A were given Ringers lactate solution 500 ml while those in group B were given 500 ml of 6% hydroxyethyl starches (HESs) and further fluid was administered in group A as ringer only and in group B as ringer and HES in a ration of 2:1. The cases were then followed to look for various outcomes in the form of urine output, serum creatinine, and mean hospital stay. Results: In this study, there were a total of 60 cases (30 in each group). The mean age in group A and B was 17.33±5.39 vs 19.11±4.79 years (p= 0.33). Mean hospital stay was 14.65±3.31 vs 13.49±2.78 days with p= 0.41. Mean urine output per day was 1645.81±143.47 vs 1705.31±165.83 ml with p= 0.43 and mean creatinine in group A and B was 1.79±0.38 vs 1.83±0.44 with p= 0.86. Conclusion: There was no significant difference in both the groups regarding urine output, creatinine, and mean hospital stay.

Material and Methods: A total of 160 patients including both males and females were selected by Non probability purposive sampling. Patients meeting inclusion and exclusion criteria were registered in the study from outpatient department after informed consent. These patients were randomly assigned into two groups. Group A was started on Cephalexin 500mg q6h Per-orally started 24 hrs before the procedure with the 4 th dose given one hour before the procedure and continued it as q6h for five days after the procedure. Group B was given Co-amoxiclav 1G Per-orally 12 hrs before the procedure with the second dose of 1G, one hour before the procedure and then same dose advised q12h for five days after PEG tube placement. Results: Male to female ratio in both groups was 2:1 with 63.3% males and 33.8% females. Patients were aged between 19-80years, divided in four age groups with 38.8% falling in age group 50-64 years. Mean age is 52.11+-13.59 years and median age 54 years. The efficacy of Cephalexin and Co-amoxiclave was 84.7% and 78.6% respectively with no significant statistical difference among two groups. Conclusion: We concluded that Cephalexin and Co-amoxiclave were both equally effective in preventing peristomal infection. of PEG tube site infection, comparison of efficacy of cephalexin and co-amoxiclav. Professional Med J 2016;23(2):187-192.

No abstract

No abstract